CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.020
+0.030 (3.03%)
At close: Jun 26, 2026, 4:00 PM EDT
1.010
-0.010 (-0.98%)
After-hours: Jun 26, 2026, 6:59 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $12.07 million as of June 26, 2026. Its market cap has decreased by -48.98% in one year.
Market Cap
12.07M
Enterprise Value
10.82M
1-Year Change
-48.98%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $12.07M, a decrease of -73.83%. That is a compound annual growth rate of -34.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 12.07M | -21.66% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 12.52M |
| SeaStar Medical Holding | 12.38M |
| BioCardia | 12.17M |
| Akari Therapeutics, | 12.14M |
| Phio Pharmaceuticals | 11.85M |
| Kiora Pharmaceuticals | 11.30M |
| Curis | 11.23M |
| OSR Health | 11.14M |